News Featured Dec 4, 2025 Arima Genomics Reports New Data at ASH 2025 Supporting More Complete Rearrangement Profiling in DLBCL With Hi-C Technology Used in Aventa Lymphoma Dec 4, 2025 Dec 4, 2025 Nov 13, 2025 Arima Genomics Announces Data Presentation at the Association of Molecular Pathology 2025 Nov 13, 2025 Nov 13, 2025 Nov 6, 2025 Arima Genomics Wins BioTech Breakthrough Award For “Clinical Diagnostics Solution of the Year” Nov 6, 2025 Nov 6, 2025 Oct 15, 2025 Arima Genomics Announces New Study Showing Aventa™ Lymphoma Test Resolves Diagnostic Ambiguity and Guides Care in B-Cell Lymphoma Cases Oct 15, 2025 Oct 15, 2025 Sep 3, 2025 Arima Genomics Introduces Aventa Lymphoma Test to Resolve Diagnostic Uncertainty in B- and T-Cell Lymphomas Sep 3, 2025 Sep 3, 2025 Jun 17, 2025 Arima Genomics Appoints Genomics Industry Veteran Tom Willis as Chief Executive Officer and Closes $22 Million Series C Financing Jun 17, 2025 Jun 17, 2025 Apr 10, 2025 New Study Shows Arima Genomics’ Technology Detects Actionable Cancer Drivers in Solid Tumors Missed by Standard Tests Apr 10, 2025 Apr 10, 2025
